| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-10 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.21 | 8e-10 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.24 | 8e-08 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-07 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |